
Please try another search
For the three months ended 31 March 2022, Kangmei Pharmaceutical Co Ltd revenues decreased 14% to RMB933.8M. Net loss decreased 81% to RMB111.4M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Interest Expense decrease of 99% to RMB2.5M (expense), Selling Expense decrease of 33% to RMB87.6M (expense).
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Revenue | 933.85 | 1066.49 | 1016.61 | 981.66 |
Gross Profit | 125.46 | -511.33 | 170.44 | 147.48 |
Operating Income | -114.39 | 11114.61 | -96.53 | -306 |
Net Income | -111.42 | 8942.49 | -95.06 | -332.71 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Assets | 15919.72 | 16054.26 | 31495.2 | 35055.98 |
Total Liabilities | 6104.59 | 6127.7 | 43037.03 | 43171.34 |
Total Equity | 9815.13 | 9926.56 | -11541.83 | -8115.36 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | -199.49 | 214.21 | 108.59 | 158.26 |
Cash From Investing Activities | -1.17 | -36.51 | 975.99 | 1003.31 |
Cash From Financing Activities | -10.46 | 1768.38 | -915.04 | -929.21 |
Net Change in Cash | -211.12 | 1946.03 | 169.56 | 232.38 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review